2025-08-29 - Analysis Report
Okay, here's a report analyzing the provided data for Merck & Co Inc (MRK), presented in English with concise analysis and numerical summaries.

## Merck & Co Inc (MRK) Stock Analysis

Merck & Co Inc is a global pharmaceutical company focused on developing and marketing innovative medicines and vaccines.

**1. Performance vs. S&P 500 (VOO):**

*   **MRK Cumulative Return:** -9.33%
*   **VOO Cumulative Return:** 102.60%
*   **Spread:** -157.2
*   **Relative Spread:** 4.9 (Indicates the current spread is near the lower end of its historical range relative to VOO.)

**Analysis:** MRK has significantly underperformed the S&P 500. The relative spread suggests this underperformance is near its historical worst compared to the index.

**Alpha/Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B) |
|------------|---------|---------|----------|--------|--------|
| 2015-2017  | 5.0%    | 58.2%   | -24.0%   | -0.0   | 134.1  |
| 2016-2018  | 43.0%   | 66.4%   | 25.0%    | -0.1   | 182.1  |
| 2017-2019  | 40.0%   | 66.4%   | 11.0%    | 0.3    | 216.8  |
| 2018-2020  | 20.0%   | 66.4%   | 0.0%     | 0.3    | 195.0  |
| 2019-2021  | -1.0%   | 65.6%   | -50.0%   | 0.3    | 191.4  |
| 2020-2022  | 13.0%   | 69.5%   | 11.0%    | 0.3    | 277.1  |
| 2021-2023  | 31.0%   | 69.5%   | 13.0%    | 0.3    | 272.3  |
| 2022-2024  | -7.0%   | 69.5%   | -33.0%   | 0.2    | 248.5  |
| 2023-2025  | -61.0%  | 71.5%   | -116.0%  | 0.5    | 207.8  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Shows fluctuating performance with significant drops in recent periods (2022-2025, 2023-2025).
*   **MDD (Maximum Drawdown):** Relatively high MDD values suggest significant potential for losses.
*   **Alpha:** Predominantly negative, indicating underperformance compared to the market risk-free rate.
*   **Beta:** Generally low (near 0.3), suggesting low correlation with market movements but rising to 0.5 recently.
*   **Cap(B):** Market capitalization varies over time.

**2. Recent Stock Price Movement:**

*   **Current Price:** 83.21
*   **Previous Close:** 84.07
*   **Change:** -1.02
*   **5-Day Moving Average:** 84.99
*   **20-Day Moving Average:** 82.76
*   **60-Day Moving Average:** 81.62

**Analysis:** The price decreased compared to the previous close, but the price is trading above its 20-day and 60-day moving averages but below the 5-day moving average. This suggests a short-term correction after a recent uptrend. The small change indicates no major volatility issues.

**3. Technical Indicators:**

*   **MRI (Market Risk Indicator):** 0.33 (Low Risk)
*   **RSI (Relative Strength Index):** 59.92 (Approaching overbought territory)
*   **PPO (Percentage Price Oscillator):** 0.05 (Positive, indicating bullish momentum)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.33)
*   **Delta_Previous_Relative_Divergence (20-day):** 1.3 (+), indicating a short-term upward trend.
*   **Expected Return (%):** -554.4 (Significant long-term underperformance vs. S&P 500)

**Analysis:** MRI suggests low market risk, RSI suggests approaching overbought territory, and PPO indicates bullish momentum. The hybrid signal suggests caution. Recent gains are noted by the positive relative divergence, but the long-term expected return is extremely negative.

**4. Recent News & Significant Events:**

*   **[2025-08-28]:**  Major business developments, regulatory changes, or market events.
*   **[2025-08-25]:**  Analysts discussing performance and outlook within industry and economic contexts.
*   **[2025-08-29]:**  Stock showing notable volatility.
*   **[2025-08-27]:**  Market experts highlighting risks and opportunities.

**Analysis:** Recent news suggests volatility and the need to monitor company announcements and market trends.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출          |
|------------|------|---------------|
| 2025-08-05 | 1.76 | 15.81 B$     |
| 2025-05-02 | 2.01 | 15.53 B$     |
| 2024-11-06 | 1.25 | 16.66 B$     |
| 2024-08-05 | 2.15 | 16.11 B$     |
| 2025-08-05 | 2.15 | 16.11 B$     |

**Analysis:** EPS and revenue have fluctuated. The latest report (2025-08-05) shows a decrease in EPS (1.76 vs. 2.15) compared to the previous quarter, while sales remain stable.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $15.81B   | 77.50%        |
| 2025-03-31 | $15.53B   | 77.98%        |
| 2024-12-31 | $15.62B   | 75.50%        |
| 2024-09-30 | $16.66B   | 75.51%        |
| 2024-06-30 | $16.11B   | 76.76%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-06-30 | $48.99B   | 9.04%    |
| 2025-03-31 | $48.34B   | 10.51%   |
| 2024-12-31 | $46.31B   | 8.08%    |
| 2024-09-30 | $44.50B   | 7.09%    |
| 2024-06-30 | $43.58B   | 12.52%   |

**Analysis:** Revenue is relatively stable. Profit margins are high. Equity and ROE have fluctuated, with recent ROE decreasing to 9.04%.

**7. 종합적인 분석 (Overall Analysis):**

MRK has significantly underperformed the S&P 500 and recent performance data suggests a negative outlook. The recent earnings show stable revenues and relatively high profit margins, but a decline in EPS. While technical indicators show some short-term positive momentum, the long-term expected return is extremely negative. Recent news suggests market volatility and the need for investors to monitor the company. From all the factors, it is considered a CAUTION.
